chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Terrible vasculitis rash; Multiple joint swelling/pain; Multiple joint swelling/pain; Recently diagnosed with HSP (Henoch-Schonlein purpura); This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the parent.  A 17 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 25May2021 (Lot number: EW0183) at the age of 16 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hashimoto's thyroiditis" (unspecified if ongoing); "PCOS" (unspecified if ongoing), notes: PCOS. Concomitant medication(s) included: LEVOTHYROXINE; LEXAPRO. Vaccination history included: Bnt162b2 (Vaccine location: Left arm, Lot number: EW0179,, Administrator route: Intramuscular,, Dose number: 1), administration date: 04May2021, when the patient was 16 years old, for COVID-19 immunization. The following information was reported: HENOCH-SCHONLEIN PURPURA (non-serious) with onset 16Jan2022, outcome "not recovered", described as "Recently diagnosed with HSP (Henoch-Schonlein purpura)"; VASCULITIC RASH (non-serious), outcome "unknown", described as "Terrible vasculitis rash"; JOINT SWELLING (non-serious), ARTHRALGIA (non-serious), outcome "unknown" and all described as "Multiple joint swelling/pain". The event "recently diagnosed with hsp (henoch-schonlein purpura)" was evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of henoch-schonlein purpura.  Additional information: The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. The patient did not have any allergies. The patient received treatment with Tylenol.  No follow-up attempts are possible. No further information is expected.
A pharmacist reported a 12 month old patient (currently 78 years old) received an injection of tetanus and diphtheria toxoids (manufacturer unknown) and subsequently developed an allergic reaction. No further information was available at the date of this report.
Twenty-four hours after vaccine given large red patch on left upper arm. Pt. says its tender but doesn't seem to mind palpitation if distracted no swelling/edema or fevers. Uses arm without limitation. Has been present  for twenty-four hours
my arm got hard at the injection site almost immediately and sore, the feeling and hardness has persisted for more than 7 days.
Pneumovax shot given 10-30-2007.  Woke 10-31-2007 to extreme pain in injected left arm- specifically in the shoulder and elbow joints. Said the pain was so intense that she "could not move her arm".  Instructed pt. to take 50mg of diphenhydramine.  Followed up with patient about 2 hrs later, and the pain had somewhat subsided.  Was not seeking medical attention at that time.
5 minutes after receiving Flu vaccine, patient developed chest pain, body tingling, blotchy rash over body, slurred speech, feeling faint, racing heart beat.
8/4/2021 ED by EMS with CC of shortness of breath. Pt tested positive for COVID-19 7/24/21. Patient has been having worsening shortness of breath, cough and fever.  He currently endorses weakness, new onset headache and diarrhea for the past 5 days.  Patient denies any current chills, vision/hearing changes, fatigue, stress pain, nausea, vomiting, abdominal pain, pain/swelling extremities, numbness/tingling, dysuria, hematuria. COVID Breakthrough. Pt received Pfizer COVID vaccine, 1st dose 1/21/2021, second dose 2/11/2021. 8/12/2021: Pt discharged home
It was reported that an 18 year old female pt received a Menomune vaccination in the left deltoid on 04/26/2000 at 2:53pm. At approx 3:05pm the pt felt faint, walked to the nursing station and admitted to nurse about feeling bad and then loss consciousness. First aid was administered, juice and cookies. Pt spontaneously regained consciousness. Pt was monitored until recovered.
approx 15hr post vax pt devel gen rash & itching;med given to pt @ ER;
Patient recieved the 5-11 year old dose in error. Client was supposed to recieve the 3-4 year old dose. Patient's mother was informed, and educated about potential for a sore arm and fever symptoms. Mother was advised to administer either tylenol or Ibuprofen before bd for the patient. Patient was monitored for 15 minutes and showed no signs of adverse reaction.
4/2/21 Vaccination #2 given,  4/3 fatigue, decreased appetite and energy, increased confusion. 4/6/21 PCP   ordered  CT angiogram of chest-no PE but suspicious infiltrates in upper lung for Covid-19 pneumonia.  DVT negative. 4/7/21 Hospital ER CT of head/neck -no stenosis, no intercranial abnormalities, Covid test negative, RIDP positive for rhinovirus and entrovirus. Neuro consult, full admit. Treated with Rocephin, zithro and oxygen, eventually vented then transferred to another location on 4/11/21. Acutely ill and in shock, Extensive workup showed no other identifiable source of infection. Died 4/18/21.
Total body ache, fatigue, red and itchy eyes, very tender and erythematous right upper arm.
Patient was seen for 18 month well visit and was behind on vaccines. The provider ordered DTaP and Prevnar to be given, however since the patient had already received a Prevnar after age of 1, this dose was not necessary. Also, from dose three to four for Prevnar it should be 6 months apart, but it had only been three months apart. Therefore, the patient will have to come back for another dose.
Vomiting and diarrhea two hours after shot. Foggy head for 4  days. Severe joint pain for for 3 days. All ended 04/02/21 except for fatigue which has been ongoing.
Left thigh became red and swollen one day after DTaP. Worse on second day . Plus warmth plus edema. No induration no tenderness.
6hr post inj.=headache nasal congestion muscle aches fatigue low grade fever. Next am-severe vertigo persistent vertigo at times-PVCS-2 days post (10/19/16).
No Adverse effect Notes, Resident administered expired Moderna Vaccine  expired on 10/13/2021.
7 am entire arm from left axillary to shoulder hard red & extremely weak very painful afebrile 97.7- 97.9.  Resp fine- lungs clear- went to ER per her physician Dr. - Ampicillin vasutech cause hives taking BENADRYL.
HEADACHE AND NAUSEA AND CHEST PAINS HAD HER CRYING BUT SHE DID NOT GO TO THE ER. IT GOT WORSE AND LASTED 5 OR 6 DAYS
Rash all over body. Fever of 102.7. Fussiness. Breathing problems.
Initial unsolicited report received from a physician's assistant on 11 August 2016. This case involves a 39-year-old male patient who was vaccinated with a dose of ADACEL (batch number: U5406AA, expiration date: 05 June 2018, dose was not reported) intramuscularly in the left deltoid on 03 August 2016. Patient's Illness at time of vaccination was reported as none and pre-existing physician diagnosed allergies, birth defects, medical conditions and concomitant medications included were not reported. On 09 August 2016, six days following the vaccination, the patient experienced painful and swollen left arm, had periodic hot sweats, had enlarged and tender lymph nodes, rash around left armpit, nausea, headache, "tight" feeling in chest and short of breath. On an unspecified date, following the vaccination the patient had elevated blood pressure. It was reported that the patient required emergency room or doctor visit. Lab data and corrective treatment were not reported. Patient had not recovered from the events. List of documents held by sender: none. Sender's Comments: Tight feeling in chest and short of breath is unlisted for DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Six days post vaccination, patient experienced, tight feeling in chest, short of breath and had an elevated blood pressure along with periodic hot sweats. Additional information regarding the investigation results to rule out the underlying cause of the reported events, relevant medical history, concurrent conditions and concomitant medications, if any are needed for complete assessment of the case. Based on the available information, no conclusion can be drawn.
Narrative: COVID infection following completion of COVID vaccine series 02/26/21 COVID vaccine dose #1 03/19/21 COVID vaccine dose #2 07/28/21 Pt presents to screening reporting cough, fatigue, fever, loss of taste/smell, shortness of breath x1 week and exposure to COVID positive family members; COVID POSITIVE 07/29/21 Pt reports cough, fatigue, shortness of breath, and resolution of fever, myalgia, and SOB; rx given for ascorbic acid, zinc, 07/30/21 Pt reports chills and cold sweats, significant dry cough, extreme fatigue, lightheadedness with exertion, severe headache, generalize muscle pain, SOB upon exertion, and sore throat 08/02/21 Pt denies fever or SOB; cough, loss of taste/smell, and muscle pain persist but pt is stable 08/04/21 Pt reports lingering symptoms but remains stable
COVID-19 INFECTION; UPPER RIGHT TEETH EXTREMELY LOOSE; UPPER RIGHT TEETH EXTREMELY SENSITIVE; VOMITING; DEHYDRATION; FAINTNESS; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 65 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: sulfa allergy, and migraine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin were not reported, batch number: unknown, expiry: unknown) 1 in total, dose, start therapy date were not reported, administered to left arm for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. On an unspecified date, the patient experienced covid-19 infection. The patient was treated with the suspect drug Paxlovid (form of administration and route of administration were not reported, batch number: unknown, expiry: unknown) dose was not reported, administered from 13-Jul-2022 to 16-JUL-2022 for treatment of COVID-19. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient received concomitant medication: Anti-Nausea (unspecified drug). On 13-JUL-2022, the patient experienced faintness, dizziness, vomiting, and dehydration and visited Emergency Room (ER). The patient was treated with fluids for dehydration. The patient reported that, she quit the paxlovid treatment after 3 of the 5 courses. On 18-JUL-2022, 2 days after quitting paxlovid, the patient experienced upper right teeth extremely loose and sensitive, felt like they were about to come out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable, and with paxlovid was drug discontinued. The patient was recovering from faintness, dehydration, upper right teeth extremely loose, upper right teeth extremely sensitive, and vomiting, and the outcome of covid-19 infection was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220752059-COVID-19 VACCINE AD26.COV2.S- faintness. The event(s) has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
A rash about 3 x 3 and rounded below right shoulder looks like shingles but does not hurt or itch; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Jul2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included autism. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jul2021, the patient experienced a rash about 3 x 3 and rounded below right shoulder which looked like shingles but did not hurt or itch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events a rash about 3 x 3 and rounded below right shoulder looks like shingles but does not hurt or itch were not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Myofacial edema and idiopathic angioedema of face, lips and tongue.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; SCARED; This spontaneous report received from a patient concerned an adult male of unknown age, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent condition included: chronic plaque psoriasis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: unknown and expiry: unknown) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drug included Skyrizi (risankizumab) (form of administration unknown, subcutaneous, batch number and expiry were not reported) dose, frequency were not reported from an unspecified date to an unspecified date in 2020 (reported as, did not take for a year) for chronic plaque psoriasis. No concomitant medications were reported.  On an unspecified date, the patient experienced covid-19 (suspected covid-19 infection and suspected clinical vaccination failure) and was scared and hence, he did not take Skyrizi for a year. His physician and physician assistant was no longer in the office and they had new one. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with risankizumab was not reported. The outcome of the suspected covid-19 infection, scared and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This case is associated with product quality complaint.; Sender's Comments: V0:20210959328-Covid-19 vaccine ad26.cov2.s-Suspected Clinical Vaccination Failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Eyes swollen, hands itchy, throat sore, headache patient took 2 BENADRYL 25mg symptoms subsided.
Cardiac arrest in emergency room x-ray dept. Autopsy related unexplained cardiomyopathy.
21 days after vaccination. Pt developed pityriasis rosea. TX consisted of Atarax at night. Anti itch cream 2x day.
Child was seen same day at ER, observed. detail medical records not available at this time dad informed us today 2-5 2020
PATIENT HAD A SYNCOPAL EPISODE IMMIDIATELY AFTER RECEIVING THE VACCINE. PATIENT SLUMPED OVER AND WAS UNRESPONSIVE FOR ABOUT 40 SECONDS. PATIENT WAS SUBSEQUENTLY RESPONSIVE AND VERBALIZED THAT SHE GETS EXTREMELY ANXIOUS WHEN SHE GETS ANY KIND OF INJECTION, IS TERRIFIED OF NEEDLES, AND THAT SHE NOW FELT OKAY. PATIENT HAD A BOTTLE OF WATER AND SAT IN THE WAITNG AREA FOR ABOUT 15 MINUTES AFTER WHICH SHE LEFT THE PHARMACY. TRIED TO CALL HER TO CHECK ON HER AFTER 3 HOURS BUT WAS NOT ABLE TO GET A HOLD OF HER.
fever; extreme tiredness; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 23Feb2021 (75-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that she was 75 years old and received the first dose of the Pfizer-BioNTech COVID-19 vaccine 2 days ago. She added she had experienced "fever" and "extreme tiredness" after vaccination. She doesn't want to receive the second dose during her vacation for she "would rather be sick at home". She specified she would contemplate to receive her second dose when she returns home around 07Apr2021. She asked how long she can go between the doses of the vaccine and still have a valid protection. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
My son pointed to his center chest and said that it was hurting. No other symptoms. He received the vaccine approx 2.5 hours prior.  He said the pain lasted until he fell asleep which was about 30 minutes after the report. The pain didn?t appear to be severe - more of a noticeable annoyance to him.  He woke up the next morning (today) and said he felt fine and has been normal so far today.
At 2 am, approximately 8 hours after receiving the vaccine, I became very dizzy. I work night shift and I needed to sit down. I started getting the sweats. After sitting for a few minutes, I tried to stand up and was very dizzy again. I immediately sat back down as I thought I was going to pass out. 30 minutes later, I had a nasty headache, the chills, pain in my knees and lower back, and neck pain. Also, I had pain at the site of the injection. I felt very nauseous. These symptoms persisted from hour 8 to 44 hours after receiving the shot.
With in 2 hours began reporting pain and swelling about 2 hours after the vaccination. She was reporting 9/10 pain at the vaccination site. Then reported body aches, vomiting, passed out, lost control of her bowel and bladder, and confusion.
sl sore throat on 10OCT98;felt worse on 11OCT98;on 12OCT98 felt like had full blown case of flu;aches & pain, watery eyes, h/a, cough, sore throat, extreme fatigue, T100;
doctor received both doses of Pfizer's COVID vaccine and resulted in zero antibodies after taking an antibody test.; This is a spontaneous report from a contactable pharmacist via medical information team. A 64-year-old male patient (doctor) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via unspecified route of administration on unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The reporter stated that doctor received both doses of Pfizer's COVID vaccine and resulted in zero antibodies after taking an antibody test. The outcome of event was unknown.  Information about lot/ batch number has been requested
Severe, stabbing and piercing feeling on the left upper side of my right breast.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 02Apr2021 at 08:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal). The patient had no known allergies. Concomitant medications included famotidine once a day (MANUFACTURER UNKNOWN), cultrelle (MANUFACTURER UNKNOWN), flaxs (MANUFACTURER UNKNOWN) and calcium carbonate, colecalciferol (CALTRATE) from unknown date for unknown indication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 10:00, the patient experienced severe, stabbing and piercing feeling on the left upper side of her right breast. After that feeling, there was pain that lasted for 4 days. As the days passed on, the pain had diminished. The pain had scared the patient that she thought of going to the ER. No therapeutic measures were taken as a result of the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe, stabbing and piercing feeling on the left upper side of her right breast was recovered on 07Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Slight headache; Double vision; This case was reported by a consumer via call center representative and described the occurrence of headache in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2021-2022 season) for prophylaxis.   On 7th December 2021, the patient received the 2nd dose of Shingrix and Influenza vaccine Quadrivalent 2021-2022 season. On 11th December 2021, 4 days after receiving Shingrix and Influenza vaccine Quadrivalent 2021-2022 season, the patient experienced headache and double vision. On an unknown date, the outcome of the headache and double vision were not recovered/not resolved.   It was unknown if the reporter considered the headache and double vision to be related to Shingrix and Influenza vaccine Quadrivalent 2021-2022 season.  Additional details were reported as follows: This case was reported by the patient himself. The patient received second dose of Shingrix and Flu shot (Unknown type/brand) together. In the early morning of 11th December 2021, the patient experienced a slight headache and double vision The patient reported that headache and double vision had remained constant since onset. The symptoms had not gotten better nor worse. The patient reported only being able to alleviate the double vision by wearing an eyepatch over one eye. The patient reported double vision returned as soon as patch was removed.  The reporter did not consent to follow-up.
diagnosed with shingles; shingle looking rash on her right side; This spontaneous case was reported by a consumer and describes the occurrence of RASH (shingle looking rash on her right side) and HERPES ZOSTER (diagnosed with shingles) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0C8A79(or z) 1A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced RASH (shingle looking rash on her right side). On 05-Apr-2021, the patient experienced HERPES ZOSTER (diagnosed with shingles). At the time of the report, RASH (shingle looking rash on her right side) and HERPES ZOSTER (diagnosed with shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment medication was valacyclovir.